Immunosuppression for dual kidney transplantation with marginal organs: The old is better yet

American Journal of Transplantation

Volumn 7, Issue 3, 2007, Pages 639-644

  Cruzado, J M ^a   Bestard, O ^a   Riera, L ^a   Torras, J ^a   Gil Vernet, S ^a   Seron D ^a   Rama, I ^a   Moreso, F ^a   Martinez Castelao A ^a   Grinyo J M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Cyclosporine; Immunosuppression; Marginal donors; Mycophenolate mofetil; Rapamycin; Renal transplantation; Thymoglobulin

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; THYMOCYTE ANTIBODY;

ADULT; AGED; ANEMIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEINURIA; SIDE EFFECT; THROMBOSIS; UNINEPHRECTOMY;

CALCINEURIN; CARDIOVASCULAR DISEASES; CYCLOSPORINE; DELAYED GRAFT FUNCTION; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; PREDNISONE; RISK; TREATMENT OUTCOME;

EID: 33847748250     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01671.x     Document Type: Article

References (20)

1. Lopes JA, Moreso F, Riera L et al. Evaluation of pre-implantation kidney biopsies: Comparison of Banff criteria to a morphometric approach. Kidney Int 2005; 67: 1595-1600.
2. Remuzzi G, Grinyó J, Ruggenenti P et al. Early experience with dual kidney transplantation in adults using expanded donor criteria. J Am Soc Nephrol 1999; 10: 2591-2598.
3. Tan JC, Alfrey EJ, Dafoe DC, Millán MT, Scandling JD. Dual-kidney transplantation with organs from expanded criteria donors: A long-term follow-up. Transplantation 2004; 78: 692-696.
4. Alfrey EJ, Boissy AR, Lerner SM, for The Participants of The Dual Kidney Registry. Dual-kidney transplants: Long-term results. Transplantation 2003; 75: 1232-1236.
5. Remuzzi G, Cravedi P, Perna A et al. Long-term outcome of renal transplant from older donors. N Engl J Med 2006; 354: 343-352.
6. Bunnapradist S, Gritsch HA, Peng A, Jordan SC, Cho JW. Dual kidneys from marginal adult donors as a source for cadaveric renal transplantation in the United States. J Am Soc Nephrol 2003; 14: 1031-1036.
7. Loverre A, Ditonno P, Crovace A et al. Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: Differential modulation by rapamycin. J Am Soc Nephrol 2004; 15: 2675-2686.
8. Lo A, Egidi MF, Gaber LWet al. Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. Transplantation 2004; 77: 1228-1235.
9. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 1997; 63: 39-47.
10. Kreis H, Cisterne JM, Land W et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 2000; 69: 1252-1260.
11. Stegall MD, Larson TS, Prieto M et al. Kidney transplantation without calcineurin inhibitors using sirolimus. Transplant Proc 2003; 35: 125S-127S.
12. Flechner SM, Goldfarb D, Modlin C et al. Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 2002; 74: 1070-1076.
13. Grinyo JM, Cruzado JM. Mycophenolate mofetil and sirolimus combination in renal transplantation. Am J Transplant 2006; 1991-1999.
14. Bishop GA, McCaughan GW, Sun J, Ross Sheil AG. Microchimerism and transplant tolerance. Immunol Today 1997; 18: 455-456.
15. Larson TS, Dean PG, Stegall MD et al. Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus. Am J Transplant 2006; 6: 514-522.
16. Senior PA, Paty BW, Cockfield SM, Ryan EA, Shapiro. Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing. Am J Transplant 2005; 5: 2318-2323.
17. Saurina A, Campistol JM, Piera C et al. Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: Changes in glomerular haemodynamics and proteinuria. Nephrol Dial Transplant 2006; 21: 488-493.
18. Izzedine H, Brocheriou I, Frances C. Post-transplantation proteinuria and sirolimus. N Engl J Med 2005; 353: 2088-2089.
19. Vanrenterghem Y, Ponticelli C, Morales JM et al. Prevalence and management of anemia in renal transplant recipients: A European survey. Am J Transplant 2003; 3: 835-845.
20. Augustine JJ, Knauss TC, Schulak JA, Bodziak KA, Siegel C, Hricik DE. Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients. Am J Transplant 2004; 4: 2001-2006.